MINERVA SURGICAL INC (UTRS) Stock Price & Overview

NASDAQ:UTRS • US60343F2056

Current stock price

1.48 USD
-0.07 (-4.52%)
At close:
1.53 USD
+0.05 (+3.38%)
After Hours:

The current stock price of UTRS is 1.48 USD. Today UTRS is down by -4.52%. In the past month the price decreased by -5.13%. In the past year, price decreased by -66.88%.

UTRS Key Statistics

52-Week Range1.37 - 14.002
Current UTRS stock price positioned within its 52-week range.
1-Month Range1.37 - 3.4919
Current UTRS stock price positioned within its 1-month range.
Market Cap
13.142M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-8.21
Dividend Yield
N/A

UTRS Stock Performance

Today
-4.52%
1 Week
+2.07%
1 Month
-5.13%
3 Months
-55.02%
Longer-term
6 Months -71.12%
1 Year -66.88%
2 Years -98.56%
3 Years N/A
5 Years N/A
10 Years N/A

UTRS Stock Chart

MINERVA SURGICAL INC / UTRS Daily stock chart

UTRS Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to UTRS. When comparing the yearly performance of all stocks, UTRS is a bad performer in the overall market: 96.67% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

UTRS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to UTRS. UTRS may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

UTRS Earnings

Next Earnings DateMar 19, 2024
Last Earnings DateNov 13, 2023
PeriodQ3 / 2023
EPS Reported-$0.81
Revenue Reported
EPS Surprise 20.59%
Revenue Surprise -11.14%

UTRS Forecast & Estimates

7 analysts have analysed UTRS and the average price target is 3.06 USD. This implies a price increase of 106.76% is expected in the next year compared to the current price of 1.48.

For the next year, analysts expect an EPS growth of 82.41% and a revenue growth 2.99% for UTRS


Analysts
Analysts82.86
Price Target3.06 (106.76%)
EPS Next Y82.41%
Revenue Next Year2.99%

UTRS Groups

Sector & Classification

Index Membership

UTRS Financial Highlights

Over the last trailing twelve months UTRS reported a non-GAAP Earnings per Share(EPS) of -8.21. The EPS increased by 58.66% compared to the year before.


Income Statements
Revenue(TTM)51.69M
Net Income(TTM)-33.45M
Industry RankSector Rank
PM (TTM) N/A
ROA -45.95%
ROE -164.78%
Debt/Equity 1.37
Chartmill High Growth Momentum
EPS Q2Q%89.88%
Sales Q2Q%-4.92%
EPS 1Y (TTM)58.66%
Revenue 1Y (TTM)3.07%

UTRS Ownership

Ownership
Inst Owners0.31%
Shares8.88M
Float2.73M
Ins Owners1799.28%
Short Float %0%
Short Ratio0

UTRS Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES18.81187.722B
ISRG INTUITIVE SURGICAL INC46.2167.678B
SYK STRYKER CORP22.27128.879B
BSX BOSTON SCIENTIFIC CORP19.77102.581B
EW EDWARDS LIFESCIENCES CORP27.1547.515B
IDXX IDEXX LABORATORIES INC38.7145.688B
BDX BECTON DICKINSON AND CO11.6945.376B
RMD RESMED INC18.833.629B
GEHC GE HEALTHCARE TECHNOLOGY13.6932.253B
DXCM DEXCOM INC25.2724.723B
ZBH ZIMMER BIOMET HOLDINGS INC10.9918.235B
HOLX HOLOGIC INC15.316.77B
PODD INSULET CORP3415.477B

About UTRS

Company Profile

UTRS logo image Minerva Surgical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Redwood City, California and currently employs 174 full-time employees. The company went IPO on 2021-10-22. Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The company has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. The company offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.

Company Info

IPO: 2021-10-22

MINERVA SURGICAL INC

101 Saginaw Drive

Redwood City CALIFORNIA US

Employees: 174

UTRS Company Website

Phone: 16502843500

MINERVA SURGICAL INC / UTRS FAQ

Can you describe the business of MINERVA SURGICAL INC?

Minerva Surgical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Redwood City, California and currently employs 174 full-time employees. The company went IPO on 2021-10-22. Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The company has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. The company offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.


What is the current price of UTRS stock?

The current stock price of UTRS is 1.48 USD. The price decreased by -4.52% in the last trading session.


Does UTRS stock pay dividends?

UTRS does not pay a dividend.


How is the ChartMill rating for MINERVA SURGICAL INC?

UTRS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists UTRS stock?

UTRS stock is listed on the Nasdaq exchange.


Can you provide the sector and industry classification for MINERVA SURGICAL INC?

MINERVA SURGICAL INC (UTRS) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


Can you provide the number of employees for MINERVA SURGICAL INC?

MINERVA SURGICAL INC (UTRS) currently has 174 employees.